{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/20/3276926/0/en/Kyverna-Presents-Longer-Term-Phase-2-Data-for-Miv-cel-in-Generalized-Myasthenia-Gravis-at-AAN-Demonstrating-Deep-Durable-Responses-through-52-Weeks.html", "message": "News view counter 671121 successfully enlarged"}